Utah Medical Products | UTMD - Ebitda

Stock Price
64.10
Daily Change
0.37 0.58%
Monthly
8.79%
Yearly
5.00%
Q1 Forecast
62.11

Utah Medical Products reported $6.19M in EBITDA for its fiscal quarter ending in March of 2023.





Ebitda Change Date
AngioDynamics USD -369K 2.01M Feb/2025
Baxter International USD 426M 36M Sep/2025
CONMED USD 80.36M 49.87M Dec/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
J&J USD 9.52B 389M Sep/2025
Medtronic USD 2.44B 139M Sep/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
OraSure Technologies USD 920K 9.87M Jun/2024
STAAR Surgical USD 34.62M 49.56M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Teleflex USD 207.62M 15.28M Jun/2025
West Pharmaceutical Services USD 218.5M 5.4M Dec/2025